All the news Showing 10 of 59 articles from: Injecting drug useGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Only treating patients with cirrhosis with DAAs will have limited impact on HCV epidemic in England Michael Carter / 24 May 2016 Targeting new hepatitis C virus (HCV) direct-acting antivirals (DAAs) at patients with cirrhosis will substantially reduce short-term incidence of end-stage liver disease (ESLD) and liver cancer (HCC) in England, according to a model ... Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs Liz Highleyman / 30 October 2015 An emergency syringe exchange program implemented after an outbreak of HIV earlier this year in the state of Indiana led to a decrease in risk behaviours including needle sharing during its first five ... Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs Roger Pebody / 28 October 2015 While epidemiologists and public health experts are excited by the potential of new hepatitis C drugs to limit onward transmission of the virus among people who inject drugs, the strategies ignore profound ... Why is injecting equipment re-used? Drug users do their own research to find out Roger Pebody / 22 October 2015 Even in the context of the relatively good access to harm reduction services in Australia, the principle reasons for people who inject drugs to re-use syringes relate to the convenience of services, ... Peer workers improve drug users’ engagement with HIV care in Ukraine Roger Pebody / 22 October 2015 An innovative programme in which peer outreach workers use a case management approach to help HIV-positive people who inject drugs to engage with medical services and to begin antiretroviral therapy appears to ... Retreat of international donors and neglect of national governments threatens harm reduction services Roger Pebody / 21 October 2015 The availability of needle and syringe programmes, opioid substitution therapy and other harm reduction services for people who inject drugs is getting even worse in many parts of the world, due to ... Opioid substitution therapy, especially in combination with needle exchange, reduces transmission of hepatitis C Roger Pebody / 20 October 2015 A pooled analysis of 25 studies has shown for the first time good evidence that methadone and other forms of opioid substitution therapy substantially reduce new hepatitis C infections. Previously, this had ... INHSU 2015 highlights hepatitis C prevention and treatment for people who inject drugs Liz Highleyman / 13 October 2015 An international group of researchers, healthcare providers, advocates, people who use drugs and people living with hepatitis C are gathering this week in Sydney for the 4th International Symposium on Health Care in ... People who inject drugs should have access to hepatitis C treatment, expert panel recommends Keith Alcorn / 12 October 2015 New recommendations on hepatitis C treatment and care for people who inject drugs encourage physicians to offer treatment to all people who inject drugs diagnosed with HCV, and to offer a comprehensive ... Young drug injectors on opioid maintenance therapy have lower risk of hepatitis C infection Liz Highleyman / 11 November 2014 Young people who inject drugs (PWID) who undergo opioid agonist maintenance therapy with methadone or buprenorphine have more than a 60% reduced risk of acquiring hepatitis C virus (HCV) over time compared to ... ← Prev1...23456Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Transfusion and medical procedures Injecting drug use Mother to child Sexual transmission Non-medical blood transfer HBV vaccination Epidemiology Screening and testing policy Health services, policy and advocacy Social issues Conference news Email bulletin archive